ASCEND BY NTHRYS
Research Abroad Products

Regulomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 37–48 of 200 project topics
Disease-Associated Regulatory Element Knowledge Base Service
Curated online database platform integrating disease-specific regulatory elements with clinical phenotypes and genomic variants. Monetizes through enterprise subscriptions ($100K-500K annually) and API licensing to clinical genomics platforms.
Regulomics Biomarker Discovery Service Platforms Click to view more details →
High-Throughput DNA Methylation Biomarker Discovery Suite
Commercial platform processing whole-genome methylation data to identify tissue-specific regulatory biomarkers for disease classification. Generates recurring revenue through per-sample analysis fees ($50-200) for diagnostic and research labs.
Regulomics Biomarker Discovery Service Platforms Click to view more details →
RNA-Regulatory Element Co-expression Analytics Platform
Integrated SaaS tool correlating regulatory element activity with RNA expression patterns across patient populations. Delivers value through biomarker licensing ($500K-2M annually) and strategic partnerships with companion diagnostics firms.
Regulomics Biomarker Discovery Service Platforms Click to view more details →
Clinical Trial Biomarker Stratification by Regulatory Signatures
Service platform helping CROs and pharma stratify trial participants using patient-specific regulatory biomarker profiles. Enables trial cost reduction of 25-35% through improved patient selection, valued at $1-3M per trial engagement.
Regulomics Biomarker Discovery Service Platforms Click to view more details →
miRNA Target Prediction SaaS for Drug Discovery
A cloud-based platform that predicts microRNA binding sites and target genes using machine learning algorithms to accelerate therapeutic target identification. This enables pharmaceutical companies to reduce drug development timelines by 40% and identify novel therapeutic opportunities worth millions in valuation.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
Long Non-Coding RNA Expression Profiling Analytics Engine
A commercial analytics platform that quantifies and visualizes lncRNA expression patterns across tissues and disease states using RNA-seq integration. This delivers actionable biomarker insights that pharmaceutical clients monetize through companion diagnostic development and precision medicine applications.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
CircRNA Stability and Function Prediction Toolkit
An enterprise software tool that predicts circular RNA stability, subcellular localization, and regulatory functions from sequence and structural data. This creates new revenue streams through licensing to biotech firms developing circRNA-based therapeutics and diagnostics.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
Small Nucleolar RNA Modification Site Discovery Platform
A specialized SaaS platform identifying pseudouridine and methylation sites in ribosomal RNA guided by snoRNA bioinformatics. This supports clients developing RNA modification-based cancer therapeutics and precision treatments commanding premium pricing in the market.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
Competing Endogenous RNA Network Mapping Software
A commercial visualization and analysis platform that maps ceRNA regulatory networks involving miRNAs, lncRNAs, and mRNAs from multi-omics data. This enables biotech firms to identify syndicated regulatory pathways for therapeutic intervention, generating subscription and licensing revenue.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
PIWI-Interacting RNA Germline Expression Monitoring Service
A managed services platform offering piRNA profiling and transposable element silencing analysis for reproductive toxicology and genetic safety assessments. This generates recurring revenue from pharmaceutical companies conducting regulatory-required safety studies and reproductive risk assessments.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
Enhancer RNA Activity and Target Gene Linking Platform
A computational platform that connects enhancer RNA transcription to target gene regulation using chromatin interaction data and machine learning models. This delivers competitive advantage for genomics service providers and research institutions licensing the platform to biotech clients.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →
Stress-Induced Small RNA Expression Biomarker Platform
An industry-grade analytics tool quantifying stress-responsive ncRNAs as biomarkers for disease progression, drug response, and patient stratification. This monetizes through licensing to diagnostics companies developing clinical-grade tests and personalized medicine applications.
Non-Coding RNA Regulomics Analytics Platforms Click to view more details →